Ordenar

Buscar

01/06/2026 A Clinician View of the EMA Explanation of the Approval of Amyloid-Targeting Therapies
Jessen, F, Fortea, J. A Clinician View of the EMA Explanation of the Approval of Amyloid-Targeting Therapies. Lancet Regional Health-Europe. 2026; 65DOI:10.1016/j.lanepe.2026.101708. PMID:42180984. IF:13.000(Q1/1D).
01/06/2026 Integrating Planetary Health in Health Guidelines (GRADE Guidance 46)
Piggott, T, Saadat, P, Herrmann, A, Stein, AT, Darzi, AJ, Haines, A, Bognanni, A, Sousa-Pinto, B, Michels, C, Akl, EA, Poluzzi, E, Senerth, E, Madrid, E, Barbic, F, de'Donato, F, Nonino, F, Vist, GE, Neumann, I, Bracchiglione, J, Bousquet, J, Meerpohl, JJ, Antó, JM, Scahill, KA, Qiu, K, Miersch, K, Saif-Ur-Rahman, K, Thinagaran, LV, Benton, L, Schwingshackl, L, Siedler, MR, Bala, MM, Metzendorf, MI, Aloosh, M, Cinquini, M, Cumpston, M, Skoetz, N, Oloyede, O, Alonso-Coello, P, Dahm, P, Wang, Q, Vieira, RJ, Morgan, RL, Murthy, S, Hofstede, S, Laot-Cabon, S, Thomander, T, Siebert, U, Leontiadis, GI, Schünemann, H. Integrating Planetary Health in Health Guidelines (GRADE Guidance 46). ANNALS OF INTERNAL MEDICINE. 2026; 179(6)DOI:10.7326/ANNALS-25-04761. PMID:42114098. IF:15.200(Q1/1D).
01/06/2026 From reserve to the full spectrum of flow quantification in risk prediction
Flotats, A. From reserve to the full spectrum of flow quantification in risk prediction. European Heart Journal-Cardiovascular Imaging. 2026; 27(6)DOI:10.1093/ehjci/jeag063. PMID:41758618. IF:6.600(Q1/1D).
01/06/2026 Randomized controlled trials in Europe: a call to action to protect national healthcare systems from the upcoming tsunami of kidney failure
Ortiz, A, Arici, M, Goumenos, DS, Adamczak, M, Eller, K, Ferreira, AC, Grandaliano, G, Jager, KJ, Lees, JS, Liakopoulos, V, Minutolo, R, Sezer, S, Azzolini, L, Fontana, M, Torres, F, Torra, R. Randomized controlled trials in Europe: a call to action to protect national healthcare systems from the upcoming tsunami of kidney failure. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2026; 41(6)DOI:10.1093/ndt/gfag007. PMID:41578941. IF:5.600(Q1/1D).
01/06/2026 Orthostatic blood pressure reduction is associated with renal damage in functionally preserved elderly hypertensive patients
Ramos-Galí, A, de la Sierra, A, Oliveras, A, Armario, P, Ayasreh, N, Arias, P, Vázquez, S, Camps, C, Castellanos, P, Calero, F, Fernández-Llama, P. Orthostatic blood pressure reduction is associated with renal damage in functionally preserved elderly hypertensive patients. NEFROLOGIA. 2026; 46(6)DOI:10.1016/j.nefro.2026.501521. PMID:42225512. IF:2.600(Q2/4D).
01/06/2026 Renal replacement therapies and adherence to EXTRIP consensus criteria in lithium poisoning: the multicenter SILITOX study
Pineda-Torcuato, A, Caballero-Bermejo, AF, Supervia, A, Salgado, E, O'Laoi, R, Sánchez, C, Córdoba, F, Farré, NR, Sanz-López, N, Ontiveros, HH, Sánchez, BAG, Gallardo, PR, Lobo-Antuña, V, Climent, B, Mora, S, Cózar-Llistó, A, Ortiz, MV, Urroz, M, Samper, VM, Román, PN, Suárez, XC, Moro, FJC, Kennedy, C, Jiménez, MDG, Gispert, MAA, Minguez, M, Sanmillán, IL, Cioccari, L, Pérez, BM, Garcia, SV, Gonzalo, JL, Burillo, G, Gutiérrez, E, Nogué-Xarau, S, Puiguriguer-Ferrando, J, Ruiz-Antorán, B. Renal replacement therapies and adherence to EXTRIP consensus criteria in lithium poisoning: the multicenter SILITOX study. EMERGENCIAS. 2026; 38(3)DOI:10.55633/s3me/040.2026. PMID:42345987. IF:6.300(Q1/1D).